about
MUGEN mouse database; animal models of human immunological diseasesCytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis.Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease.Extensive phenotypic characterization of a new transgenic mouse reveals pleiotropic perturbations in physiology due to mesenchymal hGH minigene expression.Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathologyMesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases.Host and microbiota interactions are critical for development of murine Crohn's-like ileitis.Cellular mechanisms of TNF function in models of inflammation and autoimmunity.Generation and characterization of p38beta (MAPK11) gene-targeted mice.Opposing role of tumor necrosis factor receptor 1 signaling in T cell-mediated hepatitis and bacterial infection in mice.Transmembrane TNF-α Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-β: Therapeutic Implications.Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epitheliumThe p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts.RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activitiesA20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domainRIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury
P50
Q24650850-7D5D1F52-DF13-4CD3-87F7-F7053E7BD0A6Q24810942-C7FF38C8-D6A4-437C-B7F5-9467A569151BQ30310327-0918AF02-284F-4E99-B70F-EB2D93E8029DQ33729165-9346A564-4B9E-4154-940A-92AA4BB8E9A6Q34750358-68DDE5D4-0703-43E2-ABF2-22F992DC4E52Q36502842-80175C00-B191-4738-882C-B6F2118DB0E5Q37265536-DC5153DB-2089-4FAF-952D-B38D785B6D6BQ37696065-34E24293-BD05-4EDC-82C7-99321F0A9BA3Q39891313-C78BD333-F52E-42DE-B76E-7CC22DBD0B7DQ39909202-A2128107-D593-42B6-9017-A025751079F4Q40146734-C251C13A-5F83-455C-BBC3-05CC33983A12Q41285833-B5FC85D0-19FC-425E-A63A-7C6357C2766DQ49463915-FF73DAE8-3B14-4CDF-A958-3666FFBDDC3FQ53487298-E4BE227B-49F0-4BBA-A120-EFCB1F6FF109Q90606913-76DA3D86-35E5-46F9-8F77-32639C7C458BQ92000333-1EF51204-47A3-4BF0-9A0F-67F8A4D811B4Q93112020-AB13103A-3E47-4C4B-BABE-4856B0E615D8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marietta Armaka
@ast
Marietta Armaka
@en
Marietta Armaka
@es
Marietta Armaka
@nl
Marietta Armaka
@sl
type
label
Marietta Armaka
@ast
Marietta Armaka
@en
Marietta Armaka
@es
Marietta Armaka
@nl
Marietta Armaka
@sl
altLabel
Maria Armaka
@en
prefLabel
Marietta Armaka
@ast
Marietta Armaka
@en
Marietta Armaka
@es
Marietta Armaka
@nl
Marietta Armaka
@sl
P106
P21
P31
P496
0000-0003-0985-9076
P569
2000-01-01T00:00:00Z